CODAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Codamine patents expire, and when can generic versions of Codamine launch?
Codamine is a drug marketed by Alpharma Us Pharms and is included in one NDA.
The generic ingredient in CODAMINE is hydrocodone bitartrate; phenylpropanolamine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the hydrocodone bitartrate; phenylpropanolamine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CODAMINE?
- What are the global sales for CODAMINE?
- What is Average Wholesale Price for CODAMINE?
Summary for CODAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 12 |
| Patent Applications: | 12 |
| DailyMed Link: | CODAMINE at DailyMed |
US Patents and Regulatory Information for CODAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | CODAMINE | hydrocodone bitartrate; phenylpropanolamine hydrochloride | SYRUP;ORAL | 075103-001 | Sep 29, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
